Showing results (51-60 of 60) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Plos One|October 24, 2014
Reconstitution of intestinal CD4 and Th17 T cells in antiretroviral therapy suppressed HIV-infected subjects: implication for residual immune activation from the results of a clinical trialGabriella d'Ettorre, Silvia Baroncelli, Luca Micci, et al.Therapeutic Drug Monitoring|September 25, 2013
Interindividual and intra-individual variabilities of darunavir and ritonavir plasma trough concentrations in multidrug experienced HIV patients receiving salvage regimensSilvia Baroncelli, Paola Villani, Clementina M Galluzzo, et al.The Journal of General Virology|April 24, 2004
Protective efficacy of a multicomponent vector vaccine in cynomolgus monkeys after intrarectal simian immunodeficiency virus challengeDonatella R M Negri, Silvia Baroncelli, Stefania Catone, et al.Journal of Medical Primatology|November 5, 2004
T-cell-mediated protective efficacy of a systemic vaccine approach in cynomolgus monkeys after SIV mucosal challengeZuleika Michelini, Donatella R M Negri, Silvia Baroncelli, et al.Viral Immunology|March 31, 2009
Containment of infection in tat vaccinated monkeys after rechallenge with a higher dose of SHIV89.6P(cy243)Alessandra Borsetti, Silvia Baroncelli, Maria Teresa Maggiorella, et al.Scientific Reports|February 24, 2025
Viral and immune profiles during the first wave of SARS-CoV-2 infection in hospitalized patients in Sardinia, ItalyGiulietta Venturi, Alessandra Gallinaro, Claudia Fortuna, et al.NPJ Vaccines|April 22, 2022
Persistent immunogenicity of integrase defective lentiviral vectors delivering membrane-tethered native-like HIV-1 envelope trimersAlessandra Gallinaro, Maria Franca Pirillo, Yoann Aldon, et al.Cancers|June 10, 2023
Antibody Response to the SARS-CoV-2 Vaccine and COVID-19 Vulnerability during the Omicron Pandemic in Patients with CLL: Two-Year Follow-Up of a Multicenter StudyFrancesca R Mauro, Diana Giannarelli, Clementina M Galluzzo, et al.Vaccine|August 17, 2004
Long-term protection against SHIV89.6P replication in HIV-1 Tat vaccinated cynomolgus monkeysMaria Teresa Maggiorella, Silvia Baroncelli, Zuleika Michelini, et al.DNA and Cell Biology|October 25, 2002
HIV-1 Tat-based vaccines: from basic science to clinical trialsEmanuele Fanales-Belasio, Aurelio Cafaro, Andrea Cara, et al.Pageof 6